Insmed Inc (NASDAQ: INSM) is a biopharmaceutical company that develops and commercializes therapies for serious and rare diseases. Revenue is generated through product sales of approved pharmaceutical treatments to patients and healthcare providers. The filing excerpts provided do not contain sufficient detail to characterize Insmed's competitive position, specific products, geographic footprint, segment revenue breakdown, or other operational specifics within the required evidentiary standard.

Source: SEC 10-K, filed 2026-02-19

Industry: Pharmaceutical Preparations Peers: ACADIA Pharmaceuticals Inc AMICUS THERAPEUTICS, INC. Arrowhead Pharmaceuticals Inc BioCryst Pharmaceuticals Inc Denali Therapeutics Inc Relay Therapeutics Inc Sage Therapeutics, Inc. Ultragenyx Pharmaceutical Inc Vir Biotechnology Inc